Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1983-8-11
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0028-4793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:volume |
309
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
189-90
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6866027-Adolescent,
pubmed-meshheading:6866027-Anemia, Sickle Cell,
pubmed-meshheading:6866027-Erythrocyte Aging,
pubmed-meshheading:6866027-Female,
pubmed-meshheading:6866027-Hemolysis,
pubmed-meshheading:6866027-Homozygote,
pubmed-meshheading:6866027-Humans,
pubmed-meshheading:6866027-Male,
pubmed-meshheading:6866027-Thalassemia
|
pubmed:year |
1983
|
pubmed:articleTitle |
alpha-Thalassemia reduces the hemolytic rate in homozygous sickle-cell disease.
|
pubmed:publicationType |
Letter
|